Healthcare Finance — Mortgage

The decision facing most borrowers is not whether healthcare finance — mortgage exists but whether it is the cheapest way to hold risk for the period involved. A healthcare mortgage is underwritten twice over its life: at drawdown on the going-concern value, and at every covenant test on EBITDARM cover after a management charge.

Structurally, the facility is secured on a first charge over the care home, surgery or clinic, with goodwill treated as a separate value component, written over terms of fifteen to twenty-five years on freehold registered premises, shortening sharply where the operator is new to the sector, with advances of 60% to 70% of market value on a going-concern basis, with goodwill funded only where trading is established. Lenders assess the exit before the entry: the facility is serviced from fee income and repaid on refinance or on sale of the registered business as a going concern. That ordering explains why two applicants with identical income can receive materially different terms — the credit question is whether the repayment route survives a slower market, not whether the borrower looks creditworthy today.

Activity in this segment comes from specialist care and medical lenders, challenger banks funding registered operators, non-bank lenders supporting turnaround and first-time operators and clearing bank healthcare desks. Each prices the same healthcare finance case against its own funding cost and risk appetite, which is why the same healthcare finance — mortgage case can attract offers several percentage points apart. The Financial Conduct Authority supervision shapes conduct standards and, where the borrowing is regulated, the advice and disclosure obligations that sit around the transaction.

The nearest alternatives are asset finance for the clinical equipment element alone, a bridging facility where a registration transfer sets the deadline and a sale and leaseback of the freehold to release capital. Each solves a slightly different problem: some are cheaper but slower, others are faster but priced for short exposure, and a few avoid taking a charge over the asset altogether. The right comparison is total cost over the period the money is actually needed.

Where the requirement is short and the exit is certain, a short-dated facility usually wins on total cost even at a higher rate, because the interest is charged for months rather than years. Where the asset is held for the long term and the income is stable, the opposite is true and a term facility priced on a margin priced off the regulatory rating and occupancy record, plus an arrangement fee and a specialist healthcare valuation is the cheaper way to hold the position. A healthcare mortgage is underwritten twice over its life: at drawdown on the going-concern value, and at every covenant test on EBITDARM cover after a management charge.

A broker or adviser adds most value at this point rather than at application. Comparing challenger banks funding registered operators, non-bank lenders supporting turnaround and first-time operators and clearing bank healthcare desks on a like-for-like basis, including fees and exit terms, is the step that determines the cost of the transaction — the paperwork that follows is largely administrative.

Healthcare finance — mortgage is most commonly used where an existing healthcare mortgage is refinanced at the end of its term or fixed-rate period, equity is released from a registered home to fund a second site and an established operator buys the freehold of the home or practice it currently leases. What these situations share is a mismatch between the timing of a cost and the timing of the funds that will meet it; the facility exists to bridge that mismatch at a known price rather than to fund an indefinite shortfall.

A second group of cases is structural rather than urgent: an existing healthcare mortgage is refinanced at the end of its term or fixed-rate period and equity is released from a registered home to fund a second site. Here the borrower is choosing how to hold an asset over time, and the analysis is closer to a capital-structure decision than a funding emergency. Term, covenant flexibility, and early-repayment terms matter more than speed.

The route is a poor fit where the repayment plan depends on an event outside the borrower's control, or where the requirement is better met by asset finance for the clinical equipment element alone. In those cases the honest answer is that healthcare finance — mortgage would refinance a problem instead of resolving it, and the deciding test is whether the facility is serviced from fee income and repaid on refinance or on sale of the registered business as a going concern still holds if the timetable slips by a quarter.

Eligibility for healthcare finance — mortgage is assessed on the asset first and the applicant second. Lenders test EBITDARM cover after a market-rate management charge, tested against occupancy falling several percentage points, then satisfy themselves that the facility is serviced from fee income and repaid on refinance or on sale of the registered business as a going concern remains achievable under stressed assumptions. Trading history, sector, and the quality of the security all move the answer, and a marginal case is far more often declined on evidence gaps than on the underlying numbers.

A complete submission normally contains the current regulatory inspection report and registration certificates, occupancy and fee-rate history by bed or chair over at least twenty-four months, a specialist going-concern valuation instructed by the lender and three years of accounts with EBITDARM adjustments and a market-rate management charge. Where any of these are missing, underwriters price the uncertainty rather than ignore it, so incomplete packs tend to return higher rates or lower advances rather than an outright refusal. Preparing the pack before approaching lenders is the single most effective way to protect the terms available.

Where the pack is thinner, underwriters ask for the current regulatory inspection report and registration certificates and occupancy and fee-rate history by bed or chair over at least twenty-four months before they will commit, because those items evidence the part of the case the security cannot. A healthcare mortgage is underwritten twice over its life: at drawdown on the going-concern value, and at every covenant test on EBITDARM cover after a management charge. The trade-off is cost: flexibility on criteria is almost always paid for in margin, fees, or a lower advance against value.

Pricing is built rather than quoted. The headline rate reflects a margin priced off the regulatory rating and occupancy record, plus an arrangement fee and a specialist healthcare valuation, and the effective cost only becomes visible once arrangement fees, valuation and legal costs, and any exit or early-repayment charge are added to the same calculation. Comparing two offers on rate alone routinely selects the more expensive facility.

Three variables move the price materially: where the request sits against advances of 60% to 70% of market value on a going-concern basis, with goodwill funded only where trading is established, how EBITDARM cover after a market-rate management charge, tested against occupancy falling several percentage points is evidenced, and the time the lender is exposed before the facility is serviced from fee income and repaid on refinance or on sale of the registered business as a going concern. Reducing the advance is usually the most efficient lever, because it lowers loss-given-default for the lender and therefore the margin charged. Figures discussed at enquiry stage are indicative and subject to valuation and full underwriting.

Borrowers should also price the cost of delay. Healthcare cases typically take eight to sixteen weeks, because a specialist valuation and regulatory due diligence run alongside the legal work. A healthcare mortgage is underwritten twice over its life: at drawdown on the going-concern value, and at every covenant test on EBITDARM cover after a management charge. Where a transaction has a fixed deadline, a slightly higher margin from a lender that can meet the date is frequently cheaper than a lower margin that misses it and forfeits a deposit or a negotiated purchase price.

The principal risks in healthcare finance — mortgage are a rating downgrade during the facility term triggering a covenant review rather than just affecting value, EBITDARM cover tightening as staffing costs rise faster than fee rates and key-person dependency where the registered manager is also the owner. A healthcare mortgage is underwritten twice over its life: at drawdown on the going-concern value, and at every covenant test on EBITDARM cover after a management charge. All of them are manageable when they are priced at the outset rather than discovered mid-transaction.

The most common failure mode is an exit that slips. The facility is serviced from fee income and repaid on refinance or on sale of the registered business as a going concern If that route depends on a sale or a refinance, a slower market extends the term, and extension terms are rarely as favourable as the original facility. Building contingency into the timetable is materially cheaper than negotiating it under pressure.

Independent valuation advice, early legal instruction, and a written repayment plan reviewed against a downside case address most of the exposure. Where borrowing is regulated, The Financial Conduct Authority conduct rules require suitability to be assessed and disclosed; where it is not, that discipline remains good practice rather than an obligation.

Late payment can cause you serious money problems. For help, go to moneyhelper.org.uk.